PMC:7212949 / 16327-17007
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T78 | 85-93 | Body_part | denotes | cytokine | http://purl.org/sig/ont/fma/fma84050 |
| T79 | 117-121 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
| T80 | 279-284 | Body_part | denotes | cells | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T53 | 117-121 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T103 | 63-71 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T104 | 103-109 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
| T105 | 232-240 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T106 | 469-477 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T124 | 117-121 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
| T125 | 117-121 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
| T126 | 159-167 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activity |
| T127 | 224-226 | http://purl.obolibrary.org/obo/CLO_0050509 | denotes | 27 |
| T128 | 279-284 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T129 | 335-336 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T23 | 505-520 | Chemical | denotes | glucocorticoids | http://purl.obolibrary.org/obo/CHEBI_24261 |
| T24 | 522-524 | Chemical | denotes | IL | http://purl.obolibrary.org/obo/CHEBI_63895|http://purl.obolibrary.org/obo/CHEBI_74072 |
| T26 | 527-538 | Chemical | denotes | antagonists | http://purl.obolibrary.org/obo/CHEBI_48706 |
| T27 | 553-563 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
| T28 | 565-575 | Chemical | denotes | antivirals | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T29 | 580-591 | Chemical | denotes | chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T30 | 599-617 | Chemical | denotes | hydroxychloroquine | http://purl.obolibrary.org/obo/CHEBI_5801 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T11 | 546-563 | http://purl.obolibrary.org/obo/GO_0033673 | denotes | kinase inhibitors |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T200 | 0-482 | Sentence | denotes | Currently, it is speculated that respiratory compromise due to COVID-19 is driven by cytokine-mediated injury of the lung and that interventions to reduce the activity of specific inflammatory mediators may improve outcomes.27 , 28 COVID-19 also uses ACE2 receptor to enter into cells so therapies targeting this receptor may serve as a potential treatment option.29, 30, 31, 32 There is no standard of care for the prevention or treatment of respiratory compromise in COVID-19 yet. |
| T201 | 483-680 | Sentence | denotes | Medications including glucocorticoids, IL-6 antagonists, Janus kinase inhibitors, antivirals and chloroquine and/or hydroxychloroquine are currently being studied as possible therapeutic options.33 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T686 | 160-165 | UBERON:0002107 | denotes | ctivi |
| T687 | 167-175 | UBERON:0001264 | denotes | of spec |
| T688 | 200-206 | UBERON:0002106 | denotes | rs may |
| T689 | 210-219 | GO:0006915 | denotes | rove outc |
| T690 | 248-255 | GO:0007067 | denotes | es ACE2 |
| T691 | 275-286 | CL:0000182 | denotes | nto cells s |
| T692 | 307-314 | UBERON:0009912 | denotes | this r |
| T693 | 315-326 | CL:0000542 | denotes | ceptor may |
| T694 | 350-355 | GO:0005634 | denotes | atmen |
| T695 | 388-393 | UBERON:0002107 | denotes | no st |
| T696 | 428-438 | UBERON:0001959 | denotes | r treatmen |
| T697 | 510-513 | PR:000001004 | denotes | cor |
| T698 | 533-537 | PR:000002064 | denotes | nist |
| T699 | 539-551 | CL:0000235 | denotes | Janus kinas |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 392 | 251-255 | Gene | denotes | ACE2 | Gene:59272 |
| 393 | 522-526 | Gene | denotes | IL-6 | Gene:3569 |
| 394 | 580-591 | Chemical | denotes | chloroquine | MESH:D002738 |
| 395 | 599-617 | Chemical | denotes | hydroxychloroquine | MESH:D006886 |
| 396 | 63-71 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 397 | 103-121 | Disease | denotes | injury of the lung | MESH:D055370 |
| 398 | 232-240 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 399 | 469-477 | Disease | denotes | COVID-19 | MESH:C000657245 |
2_test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 32620220-32632819-2074061 | 229-231 | 32632819 | denotes | 28 |
| 32620220-32167153-2074062 | 364-366 | 32167153 | denotes | 29 |
| 32620220-32215613-2074063 | 368-370 | 32215613 | denotes | 30 |
| 32620220-32155444-2074064 | 376-378 | 32155444 | denotes | 32 |